Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

587

Participants

Timeline

Start Date

February 17, 2009

Primary Completion Date

November 15, 2011

Study Completion Date

August 25, 2017

Conditions
Liver Cancer
Interventions
DRUG

Brivanib

Tablets, Oral, 800 mg, once daily, until disease progression or toxicity

OTHER

Placebo

Tablets, Oral, 0 mg, once daily, until disease progression or toxicity

PROCEDURE

Best Supportive Care

Trans-Arterial Chemo-Embolization (TACE) Therapy

Trial Locations (113)

100

Local Institution, Taipei

112

Local Institution, Taipei

333

Local Institution, Taoyuan Hsien

404

Local Institution, Taichung

704

Local Institution, Tainan City

1000

Local Institution, Brussels

2000

Local Institution, Rosario

8525

Local Institution, Hong Kong

10029

Mount Sinai School Of Medicine, New York

10032

Columbia University Medical Center, New York

13353

Local Institution, Berlin

14140

Local Institution, D.f.

14564

Local Institution, Kifissia

19104

University Of Pennsylvania, Philadelphia

20122

Local Institution, Milan

20133

Local Institution, Milan

23249

Mcguire Dvamc, Richmond

28034

Local Institution, Madrid

30060

Local Institution, Tianjin

30625

Local Institution, Hanover

31059

Local Institution, Toulouse

32610

UF Health Clinical Research Center, Gainesville

33006

Local Institution, Oviedo

33075

Local Institution, Bordeaux

34295

Local Institution, Montpellier

34298

Local Institution, Montpellier

35042

Local Institution, Rennes

35128

Local Institution, Padua

38043

Local Institution, Grenoble

40202

James Graham Brown Cancer Center, Louisville

43210

Ohio State University, Columbus

47014

Local Institution, Meldola (fc)

48109

3912 Taubman Center, Ann Arbor

48202

Henry Ford Health System Irb, Detroit

54511

Local Institution, Vandœuvre-lès-Nancy

54642

Local Institution, Thessaloniki

55131

Local Institution, Mainz

55905

Mayo Clinic, Rochester

56124

Local Institution, Pisa

59037

Local Institution, Lille

60126

Local Institution, Ancona

60590

Local Institution, Frankfurt

62290

Local Institution, Cuernavaca

69317

Local Institution, Lyon

72205

Univ Of Ark For Med Sci, Little Rock

75013

Local Institution, Paris

75020

Local Institution, Paris

75571

Local Institution, Paris

77030

University Of Texas, Houston

78229

The University Of Texas Health Science Center, San Antonio

79106

Local Institution, Freiburg im Breisgau

80131

Local Institution, Napoli

85259

Mayo Clinic Arizona, Scottsdale

89081

Local Institution, Ulm

92123

Sharp Clinical Oncology Research, San Diego

92350

Loma Linda University Cancer Center, Loma Linda

94010

Local Institution, Créteil

94115

Pacific Hematology Oncology Associates, San Francisco

94805

Local Institution, Villejuif

97080

Local Institution, Würzburg

97239

Oregon Health & Sci Univ, Portland

100071

Local Institution, Beijing

115478

Local Institution, Moscow

119992

Local Institution, Moscow

125367

Local Institution, Moscow

130016

Local Institution, Hangzhou

210002

Local Institution, Nanjing

430030

Local Institution, Wuhan

510060

Local Institution, Guangzhou

530021

Local Institution, Nanning

600035

Local Institution, Chennai

609735

Local Institution, Busan

610080

Local Institution, Guanzhou

682304

Local Institution, Kochi

1138655

Local Institution, Bunkyo-ku

1808610

Local Institution, Musashino-shi

2608677

Local Institution, Chiba

2778577

Local Institution, Kashiwa-shi

4118777

Local Institution, Sunto-gun

5038502

Local Institution, Ogaki-shi

5148507

Local Institution, Tsu

5378511

Local Institution, Higashinari-ku

5438555

Local Institution, Osaka

5458586

Local Institution, Osaka

5898511

Local Institution, Osaka-sayama-shi

6028566

Local Institution, Kyoto

6638501

Local Institution, Nishinomiya-shi

7500061

Local Institution, Shimonoseki-shi

7818555

Local Institution, Kochi

9308550

Local Institution, Toyama

90095-7077

Richard Finn, M.D., Los Angeles

C1264AAA

Local Institution, Capital Federal

41825-010

Local Institution, Salvador

40050-410

Local Institution, Salvador - Ba

90610-000

Local Institution, Porto Alegre

05403-010

Local Institution, São Paulo

T2N 4Z6

Local Institution, Calgary

V5Z 1M9

Local Institution, Vancouver

M5G 2N2

Local Institution, Toronto

06120

Local Institution, Halle

700 053

Local Institution, Kolkata

110 070

Local Institution, New Delhi

232-0024

Local Institution, Yokohama

104-0045

Local Institution, Chuo-ku

05440

Local Institution, Toluca

00910

Local Institution, San Juan

700-721

Local Institution, Daegu

410-769

Local Institution, Gyeonggi-do

120-752

Local Institution, Seoul

135-710

Local Institution, Seoul

136-701

Local Institution, Seoul

138-736

Local Institution, Seoul

08036

Local Institution, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY